Back to Treatments

Treatment

Mifamurtide (Adjuvant for High-Grade Osteosarcoma, non-US approval)

1
Conditions
15
Trials
2,000
Participants
60%
Average Safety

Condition Evidence

Malignant neoplasm of bone and articular cartilage

15 trials · 2,000 participants

55% effectiveness · 60% safety
Mifamurtide (Adjuvant for High-Grade Osteosarcoma, non-US approval) | DFDA